SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children

References

• World Health Organization. WHO characterizes COVID‐19 as a pandemic; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Accessed June 15, 2021.
   Google Scholar
• She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol. 2020;92(7):747–754. doi:10.1002/jmv.25807
   PubMed Web of Science ®Google Scholar
• Epidemiology Working Group for Ncip Epidemic Response CCfDC, Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151. Chinese. doi:10.3760/cma.j.issn.0254-6450.2020.02.003
   PubMedGoogle Scholar
• COVID-19 coronavirus pandemic; 2021. Available from: https://www.worldometers.info/coronavirus/. Accessed June 15, 2021.
   Google Scholar
• Association TAAoPatCsH. Children and COVID-19: state-level data report; 2021. Available from: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/. Accessed June 15, 2021.
   Google Scholar
• World Health Organization. Timeline: WHO’s COVID-19 response; 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline. Accessed June 15, 2021.
   Google Scholar
• Bolanos-Almeida CE, Espitia Segura OM. Clinical and epidemiologic analysis of COVID-19 children cases in Colombia PEDIACOVID. Pediatr Infect Dis J. 2021;40(1):7–11. doi:10.1097/INF.0000000000002952
   Web of Science ®Google Scholar
• Slomka A, Kowalewski M, Zekanowska E. Coronavirus disease 2019 (COVID-19): a short review on hematological manifestations. Pathogens. 2020;9(6):493. doi:10.3390/pathogens9060493
   PubMed Web of Science ®Google Scholar
• Cheung CKM, Law MF, Lui GCY, Wong SH, Wong RSM. Coronavirus disease 2019 (COVID-19): a haematologist’s perspective. Acta Haematol. 2021;144(1):10–23. doi:10.1159/000510178
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
   PubMed Web of Science ®Google Scholar
• Ferrari D, Motta A, Strollo M, et al. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem Lab Med. 2020;58(7):1095–1099. doi:10.1515/cclm-2020-0398
   PubMed Web of Science ®Google Scholar
• Lee PI, Hu YL, Chen PY, et al. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53(3):371–372. doi:10.1016/j.jmii.2020.02.011
   PubMedGoogle Scholar
• Zare-Zardini H, Soltaninejad H, Ferdosian F, et al. Coronavirus disease 2019 (COVID-19) in children: prevalence, diagnosis, clinical symptoms, and treatment. Int J Gen Med. 2020;13:477–482. doi:10.2147/IJGM.S262098
   PubMed Web of Science ®Google Scholar
• Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an Observational Cohort Study. Lancet Infect Dis. 2020;20(6):689–696. doi:10.1016/S1473-3099(20)30198-5
   PubMed Web of Science ®Google Scholar
• Chiappelli F, Khakshooy A, Greenberg G. COVID-19 immunopathology and immunotherapy. Bioinformation. 2020;16(3):219–222. doi:10.6026/97320630016219
   PubMed Web of Science ®Google Scholar
• Zheng HY, Zhang M, Yang CX, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541–543. doi:10.1038/s41423-020-0401-3
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a Descriptive and Predictive Study. Signal Transduct Target Ther. 2020;5(1):33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Tufan A, Avanoglu Guler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50(SI–1):620–632. doi:10.3906/sag-2004-168
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi:10.3389/fimmu.2020.00827
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xu H, Yang M, et al. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. J Clin Virol. 2020;127:104366. doi:10.1016/j.jcv.2020.104366
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):131–134. doi:10.1002/ajh.25774
   PubMed Web of Science ®Google Scholar
• Jia R, Wang X, Liu P, et al. Mild cytokine elevation, moderate CD4(+) T cell response and abundant antibody production in children with COVID-19. Virol Sin. 2020;35(6):734–743. doi:10.1007/s12250-020-00265-8
   PubMed Web of Science ®Google Scholar
• Bourkhissi L, Fakiri KE, Nassih H, et al. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Med Insights Pediatr. 2020;14:1179556520955177. doi:10.1177/1179556520955177
   Google Scholar
• Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313–1314. doi:10.1001/jama.2020.2131
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663–1665. doi:10.1056/NEJMc2005073
   PubMed Web of Science ®Google Scholar
• Keski H. Hematological and inflammatory parameters to predict the prognosis in COVID-19. Indian J Hematol Blood Transfus. 2021:1–9. Online ahead of print. doi:10.1007/s12288-021-01407-y
   Web of Science ®Google Scholar
• Bunte K, Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int J Mol Sci. 2019;20(14):3394. doi:10.3390/ijms20143394
   PubMed Web of Science ®Google Scholar
• Dutzan N, Abusleme L. T helper 17 cells as pathogenic drivers of periodontitis. Adv Exp Med Biol. 2019;1197:107–117. doi:10.1007/978-3-030-28524-1_9
   PubMed Web of Science ®Google Scholar
• Zhao D, Yao F, Wang L, et al. A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias. Clin Infect Dis. 2020;71(15):756–761. doi:10.1093/cid/ciaa247
   PubMed Web of Science ®Google Scholar
• Tosato F, Giraudo C, Pelloso M, et al. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients. Clin Chem Lab Med. 2020;58(7):1149–1151. doi:10.1515/cclm-2020-0319
   PubMed Web of Science ®Google Scholar
• Yarali N, Akcabelen YM, Unal Y, Parlakay AN. Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19. Pediatr Blood Cancer. 2021;68(2):28596. doi:10.1002/pbc.28596
   Web of Science ®Google Scholar
• Guner Ozenen G, Sahbudak Bal Z, Umit Z, et al. Demographic, clinical, and laboratory features of COVID-19 in children: the role of mean platelet volume in predicting hospitalization and severity. J Med Virol. 2021;93(5):3227–3237. doi:10.1002/jmv.26902
   PubMed Web of Science ®Google Scholar
• Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020;67(12):28745. doi:10.1002/pbc.28745
   Web of Science ®Google Scholar
• Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334–346. doi:10.1056/NEJMoa2021680
   PubMed Web of Science ®Google Scholar
• Belhadjer Z, Meot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429–436. doi:10.1161/CIRCULATIONAHA.120.048360
   PubMed Web of Science ®Google Scholar
• Cheung EW, Zachariah P, Gorelik M, et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020;324(3):294–296. doi:10.1001/jama.2020.10374
   PubMed Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an Observational Cohort Study. Lancet. 2020;395(10239):1771–1778. doi:10.1016/S0140-6736(20)31103-X
   PubMed Web of Science ®Google Scholar
• Shahin W, Rabie W, Alyossof O, et al. COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease: a Single-Center Study. Saudi Med J. 2021;42(3):299–305. doi:10.15537/smj.2021.42.3.20200625
   PubMed Web of Science ®Google Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):6–12. doi:10.1016/j.jinf.2020.04.002
   Web of Science ®Google Scholar
• Fan CY, Wang AL, Wang A-L, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020;81(1):51–60. doi:10.1016/j.jinf.2020.04.012
   Web of Science ®Google Scholar
• Xu B, Tan C, Huang Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856–862. doi:10.1002/jmv.25871
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou X, Yan H, et al. CANPT score: a tool to predict severe COVID-19 on admission. Front Med (Lausanne). 2021;8:608107. doi:10.3389/fmed.2021.608107
   PubMed Web of Science ®Google Scholar
• Liu J, Tu C, Zhu M, et al. The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: a Retrospective Case-Control Study. Medicine (Baltimore). 2021;100(8):23996. doi:10.1097/MD.0000000000023996
   Web of Science ®Google Scholar
• Ghazanfari T, Salehi MR, Namaki S, et al. Interpretation of hematological, biochemical, and immunological findings of COVID-19 disease: biomarkers associated with severity and mortality. Iran J Allergy Asthma Immunol. 2021;20(1):46–66. doi:10.18502/ijaai.v20i1.5412
   PubMed Web of Science ®Google Scholar
• Storch-de-gracia P, Leoz-Gordillo I, Andina D, et al. Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection. An Pediatr (Engl Ed). 2020;93(5):323–333. doi:10.1016/j.anpedi.2020.07.025
   Web of Science ®Google Scholar
• Garcia-Salido A, de Carlos Vicente JC, Belda Hofheinz S, et al. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a Multicentre Study in pediatric intensive care units in Spain. Crit Care. 2020;24(1):666. doi:10.1186/s13054-020-03332-4
   PubMed Web of Science ®Google Scholar
• Liu X, Lv J, Gan L, et al. Comparative analysis of clinical characteristics, imaging and laboratory findings of different age groups with COVID-19. Indian J Med Microbiol. 2020;38(1):87–93. doi:10.4103/ijmm.IJMM_20_133
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238
   PubMed Web of Science ®Google Scholar
• Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19: a Cross-Sectional Study of 148 patients. Diabetes Metab Syndr. 2020;14(6):2099–2102. doi:10.1016/j.dsx.2020.10.029
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Yan B, Yang J, Xie Y, et al. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J. 2021;14(3):100521. doi:10.1016/j.waojou.2021.100521
   PubMed Web of Science ®Google Scholar
• Liu F, Xu A, Zhang Y, et al. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis. 2020;95:183–191. doi:10.1016/j.ijid.2020.03.013
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a Descriptive Study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Qian GQ, Yang NB, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 2020;113(7):474–481. doi:10.1093/qjmed/hcaa089
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–1208. doi:10.1007/s00277-020-04019-0
   PubMed Web of Science ®Google Scholar
• Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets. 2020;31(5):674–679. doi:10.1080/09537104.2020.1760230
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
   PubMed Web of Science ®Google Scholar
• Pranata R, Lim MA, Yonas E, et al. Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis. Epidemiol Infect. 2021;149:40. doi:10.1017/S0950268821000236
   Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472. doi:10.1111/jth.14848
   PubMed Web of Science ®Google Scholar
• Elghoudi A, Aldhanhani H, Ghatasheh G, et al. COVID-19 in children and young adolescents in Al Ain, United Arab Emirates- a Retrospective Cross-Sectional Study. Front Pediatr. 2020;8:603741. doi:10.3389/fped.2020.603741
   PubMed Web of Science ®Google Scholar
• Bhumbra S, Malin S, Kirkpatrick L, et al. Clinical features of critical coronavirus disease 2019 in children. Pediatr Crit Care Med. 2020;21(10):948–953. doi:10.1097/PCC.0000000000002511
   Web of Science ®Google Scholar
• Alfraij A, Bin Alamir AA, Al-Otaibi AM, et al. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) in critically ill pediatric patients admitted to the intensive care unit: a Multicenter Retrospective Cohort Study. J Infect Public Health. 2021;14(2):193–200. doi:10.1016/j.jiph.2020.12.010
   PubMed Web of Science ®Google Scholar
• Davies P, Evans C, Kanthimathinathan HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a Multicentre Observational Study. Lancet Child Adolesc Health. 2020;4(9):669–677. doi:10.1016/S2352-4642(20)30215-7
   PubMedGoogle Scholar
• Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533–1541. doi:10.1002/jmv.25767
   PubMed Web of Science ®Google Scholar
• Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174–180. doi:10.1016/j.cca.2020.04.024
   PubMed Web of Science ®Google Scholar
• Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a Multi-Center Study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–393. doi:10.1016/j.jinf.2020.02.016
   PubMed Web of Science ®Google Scholar
• Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806. doi:10.1002/jmv.25783
   PubMed Web of Science ®Google Scholar
• Mitchell WB, Davila J, Keenan J, et al. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy. Pediatr Blood Cancer. 2021;68(7):28975. doi:10.1002/pbc.28975
   PubMed Web of Science ®Google Scholar
• Horiuchi H, Morishita E, Urano T, et al. COVID-19-related thrombosis in Japan: final report of a questionnaire-based survey in 2020. J Atheroscler Thromb. 2021;28(4):406–416. doi:10.5551/jat.RPT001
   PubMed Web of Science ®Google Scholar
• Lio KU, Rali P. Coagulopathy in COVID-19. Lung India. 2021;38(Supplement):53–57. doi:10.4103/lungindia.lungindia_226_20
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120. doi:10.1515/cclm-2020-0188
   PubMed Web of Science ®Google Scholar
• Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113(1):45–57. doi:10.1007/s12185-020-03029-y
   PubMed Web of Science ®Google Scholar
• Hartmann J, Ergang A, Mason D, et al. The role of TEG analysis in patients with COVID-19-associated coagulopathy: a systematic review. Diagnostics (Basel). 2021;11(2). doi:10.3390/diagnostics11020172
   Google Scholar
• Al-Ghafry M, Aygun B, Appiah-Kubi A, et al. Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients. Pediatr Blood Cancer. 2020;67(12):28737. doi:10.1002/pbc.28737
   Web of Science ®Google Scholar
• Al-Ghafry M, Vagrecha A, Malik M, et al. Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: coagulation profiles and rotational thromboelastometry in a MIS-C cohort. J Thromb Haemost. 2021. Online ahead of print. doi:10.1111/jth.15340
   PubMed Web of Science ®Google Scholar
• Taneri PE, Gomez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763–773. doi:10.1007/s10654-020-00678-5
   PubMed Web of Science ®Google Scholar
• Zheng F, Tang W, Li H, et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24(6):3404–3410. doi:10.26355/eurrev_202003_20711
   PubMed Web of Science ®Google Scholar
• Henry BM, Benoit JL, Benoit S, et al. Red blood cell distribution width (RDW) predicts COVID-19 severity: a Prospective, Observational Study from the Cincinnati SARS-CoV-2 emergency department cohort. Diagnostics (Basel). 2020;10(9). doi:10.3390/diagnostics10090618
   PubMedGoogle Scholar
• Cen Y, Chen X, Shen Y, et al. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a Multi-Centre Observational Study. Clin Microbiol Infect. 2020;26(9):1242–1247. doi:10.1016/j.cmi.2020.05.041
   PubMed Web of Science ®Google Scholar
• Benoit JL, Benoit SW, de Oliveira MHS, et al. Anemia and COVID-19: a prospective perspective. J Med Virol. 2021;93(2):708–711. doi:10.1002/jmv.26530
   PubMed Web of Science ®Google Scholar
• Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190(1):29–31. doi:10.1111/bjh.16794
   PubMed Web of Science ®Google Scholar
• Taherifard E, Taherifard E, Movahed H, et al. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021;26(1):225–239. doi:10.1080/16078454.2021.1881225
   PubMed Web of Science ®Google Scholar
• Deng YY, Zheng Y, Cai GY, et al. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus. Chin Med J (Engl). 2020;133(9):1129–1131. doi:10.1097/CM9.0000000000000783
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Rajput U, Dawre R, et al. Severe malnutrition and anemia are associated with severe COVID in infants. J Trop Pediatr. 2021;67(1):fmaa084. doi:10.1093/tropej/fmaa084
   PubMed Web of Science ®Google Scholar
• Al Yazidi LS, Al Hinai Z, Al Waili B, et al. Epidemiology, characteristics and outcome of children hospitalized with COVID-19 in Oman: a Multicenter Cohort Study. Int J Infect Dis. 2021;104:655–660. doi:10.1016/j.ijid.2021.01.036
   PubMed Web of Science ®Google Scholar
• Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective Observational Study. BMJ. 2020;369:m2094. doi:10.1136/bmj.m2094
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response--lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45(1):18–32. doi:10.1258/acb.2007.007167
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi:10.1016/j.ebiom.2020.102763
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-6
   PubMed Web of Science ®Google Scholar
• Addeo A, Friedlaender A. Cancer and COVID-19: unmasking their ties. Cancer Treat Rev. 2020;88:102041. doi:10.1016/j.ctrv.2020.102041
   PubMed Web of Science ®Google Scholar
• Yang L, Chai P, Yu J, Fan X. Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants. Cancer Biol Med. 2021;18(1):298–307. doi:10.20892/j.issn.2095-3941.2020.0559
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a Multicenter Study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
   PubMed Web of Science ®Google Scholar
• de Melo AC, Thuler LCS, da Silva JL, et al. Cancer in-patients with COVID-19: a report from the Brazilian national cancer institute. PLoS One. 2020;15(10):0241261. doi:10.1371/journal.pone.0241261
   Web of Science ®Google Scholar
• Kim JS, Lee KH, Kim GE, et al. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review. Eur Rev Med Pharmacol Sci. 2020;24(22):11926–11933.
   PubMed Web of Science ®Google Scholar
• Madhusoodhan PP, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience. Pediatr Blood Cancer. 2021;68(3):28843. doi:10.1002/pbc.28843
   PubMed Web of Science ®Google Scholar
• Kainth MK, Goenka PK, Williamson KA, et al. Early experience of COVID-19 in a US children’s hospital. Pediatrics. 2020;146(4):e2020003186. doi:10.1542/peds.2020-003186
   PubMed Web of Science ®Google Scholar
• Andre N, Rouger-Gaudichon J, Brethon B, et al. COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms? Pediatr Blood Cancer. 2020;67(7):28392. doi:10.1002/pbc.28392
   PubMed Web of Science ®Google Scholar
• Marcia M, Vania B, Pruccoli G, et al. Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19. Pediatr Blood Cancer. 2020;67(11):28423. doi:10.1002/pbc.28423
   Web of Science ®Google Scholar
• Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2. J Pediatric Infect Dis Soc. 2020;9(6):701–715. doi:10.1093/jpids/piaa045
   PubMed Web of Science ®Google Scholar